Shape Therapeutics Raises $112M to Develop RNA-based Gene Therapies

Shape Therapeutics Raises $112M to Develop RNA-based Gene Therapies

300215

Shape Therapeutics Raises $112M to Develop RNA-based Gene Therapies

Shape Therapeutics has raised $112 million in financing to support work into developing its portfolio of RNA technologies to potentially treat genetic diseases, including Rett syndrome. “We have witnessed the power of [messenger RNA] in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinson’s disease, Alzheimer’s disease … and Rett syndrome,”…

You must be logged in to read/download the full post.